IFP Advisors
OLMA icon

IFP Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

IFP Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$52 Hold
6
– – ﹤0.01% 5056
2026
Q2 		$75 Hold
6
– – ﹤0.01% 4991
2026
Q1 		$89 Hold
6
– – ﹤0.01% 4755
2025
Q4 		$150 Hold
6
– – ﹤0.01% 4522
2025
Q3 		$59 Buy
+6
New +$36 ﹤0.01% 4633
2025
Q2 		– Hold
0
– – – 3909
2025
Q1 		– Hold
0
– – – 4202
2024
Q4 		– Hold
0
– – – 4434

Other funds holding OLMA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

IFP Advisors's OLMA Position: Q3 2026 in Review

IFP Advisors held its Olema Pharmaceuticals (OLMA) position steady in Q3 2026 at 6 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #5056.

IFP Advisors first reported a position in OLMA in Q3 2025 and has held it in 5 quarters since. The position peaked at $150 in Q4 2025. 33 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • IFP Advisors held 6 shares of Olema Pharmaceuticals worth $52 as of Q3 2026.
  • IFP Advisors left its Olema Pharmaceuticals share count unchanged in Q3 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5056 holding.
  • IFP Advisors first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • IFP Advisors's Olema Pharmaceuticals position peaked at $150 in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.